Last reviewed · How we verify
NCT04252196
Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly.BAC.U
NA trial testing usability evaluation of medical device in Healthy in 4 participants. Completed in 28 January 2019.
28 January 2019
Quick facts
| Lead sponsor | Bright Cloud International Corp |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 4 |
| Start date | 15 August 2018 |
| Primary completion | 28 January 2019 |
| Estimated completion | 28 January 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- usability evaluation of medical device
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Bright Cloud International Corp — full company profile →
Who can join
Adults 50 to 80, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This usability study is to test the basic functionality of the BrightArm Compact (BAC) system. The BAC is a motorized rehabilitation platform to offer gravity bearing for weak upper extremity. It has a medical grade PC which hosts numerous interactive, adaptable computer games, played using BrightBrainer Grasp (BBG) controllers. The device is passive, in that no actuators apply forces on the patient. Further, the patient is free to lift that arm, nothing restricts the arms movement away from the BAC table.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04252196
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Bright Cloud International Corp trials
Trials by the same sponsor.
- NCT04732182 — Telerehabilitation Alzheimer's Disease Feasibility (TADF) · NA · unknown
- NCT04972019 — Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study · NA · unknown
- NCT04731311 — Telerehabilitation Alzheimer's Disease Usability (TADU) · NA · completed
- NCT04839588 — Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study · completed
- NCT04724954 — Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly (Clinical Trial) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04252196 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bright Cloud International Corp
- Last refreshed: 5 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04252196.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing